Use of limk-1, its analogues and ligands for the production...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/45 (2006.01)

Patent

CA 2548016

The present invention relates to LIMK-1, a LIMK-1-analogue or LIMK-1 ligand for the binding to GPIIb and/or activation or inhibition of GPIIb/Illa downstream signaling, for the production of a medicament for the prevention or treatment of a thrombus formation or blood clotting disease, methods of screening a LIMK-1 analogue or a LIMK-1 ligand and a method for producing a medicament for the treatment of a thrombus formation or blood clotting disease.

La présente invention a trait à l'utilisation de LIMK-1, un analogue de LIMK-1 ou un ligand de LIMK-1 pour la liaison à la glycoprotéine la glycoprotéine II et/ou l'activation ou l'inhibition de la signalisation en aval de la glycoprotéine IIb/Illa, pour la production d'un médicament pour la prévention d'une formation de thrombus ou d'une maladie de coagulation sanguine, à des procédés de criblage d'un analogue de LIMK-1 ou d'un ligand de LIMK-1 et à un procédé pour la production d'un médicament pour le traitement d'une formation de thrombus ou d'une maladie de coagulation sanguine.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of limk-1, its analogues and ligands for the production... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of limk-1, its analogues and ligands for the production..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of limk-1, its analogues and ligands for the production... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1394551

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.